Deerfield Management Announces Collaboration with AWS to Accelerate AI-Driven Healthcare Innovation and Care Delivery

NEW YORK, Nov. 9, 2026 /PRNewswire/ -- Deerfield Management, an investment firm dedicated to advancing healthcare, today announced a collaboration with Amazon Web Services (AWS) aimed to accelerate the development and scaling of AI-native healthcare and life sciences companies.

The collaboration brings together AWS's generative AI and cloud services with Deerfield Intelligence's team of AI engineers and the innovation ecosystem of the firm's affiliate, Cure, with the goal to enable selected Deerfield's portfolio companies to deploy agentic AI systems across drug discovery, operational automation, and care delivery. Beyond portfolio company applications, the collaboration will aim to strengthen Deerfield's capabilities, integrating AWS's AI services into the firm's research, evaluation, and operating processes.

As part of the expanded relationship, AWS will be designated as a preferred AI provider for Deerfield and selected portfolio companies. The firm's Deerfield Intelligence and Deerfield Discovery and Development (3DC) teams will receive access to AI and cloud technology from AWS, as well as technical support, to scale proprietary healthcare AI products and disseminate AI capabilities across interested companies in Deerfield's portfolio. Select Deerfield portfolio companies will also be provided access to AWS's AI and cloud technology, along with technical enablement and training on topics including large-scale model training, inference optimization, and healthcare-specific managed services.

"This collaboration aims to drive the development of the next generation of AI-powered healthcare organizations," said Dan Sheeran, Vice President and General Manager of Healthcare and Life Sciences at AWS. "With support from AWS, interested Deerfield portfolio companies can be equipped with AI services specific to supporting healthcare and life sciences needs like Amazon Bio Discovery, as well as agentic services like Amazon Bedrock AgentCore to build AI agents and support organizations at a scale that wouldn't have been feasible only a few years ago."

"Deerfield is working to build an ambitious AI-native platform in healthcare," said Jim Flynn, Managing Partner at Deerfield. "Our Intelligence team is developing models that aim to transform how we source opportunities, evaluate science, and accelerate portfolio companies. With access to AWS healthcare services, we hope to empower companies to accelerate their development timelines as they build their own clinical solutions."

The collaboration builds on early momentum within the Deerfield portfolio. Ascertain, a healthcare technology company backed by Deerfield, uses AWS services as part of its agentic AI platform, which automates complex clinical and administrative workflows, such as case management and prior authorization, rather than making legacy processes incrementally more efficient.

"We built Ascertain to give clinicians time back by automating the administrative burden in care, and we believe AWS's purpose-built services for the healthcare industry will help us scale these capabilities," said Mark Michalski, M.D., Chief Information Officer at Deerfield and CEO of Ascertain. "We believe Deerfield's collaboration with AWS and the AI and cloud services it makes available to Ascertain and other portfolio companies is part of a foundation with the potential to make AI-driven transformation possible at scale."

The AWS collaboration builds on Deerfield's history of supporting companies across the healthcare industry. Deerfield's headquarters at Cure, a healthcare innovation campus in New York City, sits at the center of one of the world's densest healthcare ecosystems, home to leading academic medical centers, a growing biotech sector, and a deep network of clinicians and investors. The Deerfield team spans more than 190 professionals, including 60+ MDs, JDs, and PhDs. Looking ahead, Deerfield and AWS plan to co-host joint programming at Cure, activating the space as a shared hub for the healthcare innovation community.

About Deerfield Management
Deerfield is an investment management firm committed to advancing healthcare through investment, intelligence, and philanthropy. The Deerfield ecosystem is headquartered at Cure, a healthcare innovation campus in New York City, and includes Deerfield Discovery and Development (3DC), the firm's internal research & development engine, and Deerfield Intelligence, the firm's data, technology, and artificial intelligence arm. Deerfield works across the healthcare ecosystem to connect people, capital, ideas, and technology in bold, collaborative, and inclusive ways. For more information, please visit www.deerfield.com.

CONTACT: Jessica Sagers, PhD, Head of Communications, [email protected] 

SOURCE Deerfield Management Company, L.P.